Insider · CIK 0001352455

Wasman Jane

Reports to the SEC for 4 companies · SOUTH SAN FRANCISCO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001352455

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-05-15	RIGLRIGEL PHARMACEUTICALS INCA Award	Director	AAward	+5,750 sh	—	—	18,250
2026-01-07	SLSSELLAS Life Sciences Group, Inc.A Award	Director	AAward	+50K sh	—	—	92,900
2025-05-30	SLSSELLAS Life Sciences Group, Inc.P Purchase	Director	PPurchase	+20K sh	$1.69	+$33.8K	30,400
2025-05-23	RIGLRIGEL PHARMACEUTICALS INCA Award	Director	AAward	+2,500 sh	—	—	12,500
2025-05-23	RIGLRIGEL PHARMACEUTICALS INC · Stock Option (Right to Buy)A Award	Director	AAward	+3,000 sh	—	—	3,000
2025-01-10	SLSSELLAS Life Sciences Group, Inc.A Award	Director	AAward	+12.5K sh	—	—	22,900
2025-01-10	SLSSELLAS Life Sciences Group, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+18.5K sh	—	—	18,500
2024-05-25	RIGLRIGEL PHARMACEUTICALS INCA Award	Director	AAward	+25K sh	—	—	100,000
2024-05-25	RIGLRIGEL PHARMACEUTICALS INC · Stock Option (Right to Buy)A Award	Director	AAward	+30K sh	—	—	30,000
2024-01-22	SLSSELLAS Life Sciences Group, Inc.A Award	Director	AAward	+6,000 sh	—	—	10,400
2024-01-22	SLSSELLAS Life Sciences Group, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+10K sh	—	—	10,000
2023-05-26	RIGLRIGEL PHARMACEUTICALS INCA Award	Director	AAward	+25K sh	—	—	75,000
2023-05-26	RIGLRIGEL PHARMACEUTICALS INC · Stock Option (Right to Buy)A Award	Director	AAward	+30K sh	—	—	30,000
2023-02-02	SLSSELLAS Life Sciences Group, Inc.A Award	Director	AAward	+2,500 sh	—	—	4,400
2023-02-02	SLSSELLAS Life Sciences Group, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+9,500 sh	—	—	9,500
2023-01-09	ATHERSYS, INC / NEWA Award	Director	AAward	+22.3K sh	—	—	35,141
2022-09-16	ATHERSYS, INC / NEWA Award	Director	AAward	+12.8K sh	—	—	12,820
2022-09-16	ATHERSYS, INC / NEWStock Option (right to purchase)A Award	Director	AAward	+32K sh	—	—	64,084
2022-05-20	RIGLRIGEL PHARMACEUTICALS INCA Award	Director	AAward	+25K sh	—	—	50,000
2022-05-20	RIGLRIGEL PHARMACEUTICALS INC · Stock Option (Right to Buy)A Award	Director	AAward	+30K sh	—	—	30,000
2022-01-31	SLSSELLAS Life Sciences Group, Inc.A Award	Director	AAward	+1,900 sh	—	—	1,900
2022-01-31	SLSSELLAS Life Sciences Group, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+7,125 sh	—	—	7,125
2021-06-15	ATHERSYS, INC / NEWNonQualified Stock Option (right to purchase)A Award	Director	AAward	+50K sh	—	—	50,000
2021-05-19	RIGLRIGEL PHARMACEUTICALS INCA Award	Director	AAward	+25K sh	—	—	25,000
2021-05-19	RIGLRIGEL PHARMACEUTICALS INC · Stock Option (Right to Buy)A Award	Director	AAward	+30K sh	—	—	30,000
2021-03-04	SLSSELLAS Life Sciences Group, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+7,500 sh	—	—	7,500
2020-11-12	ATHERSYS, INC / NEWNonQualified Stock Option (right to purchase)A Award	Director	AAward	+100K sh	—	—	100,000
2020-05-15	RIGLRIGEL PHARMACEUTICALS INC · Stock Option (Right to Buy)A Award	Director	AAward	+55K sh	—	—	55,000
2020-03-12	SLSSELLAS Life Sciences Group, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+6,500 sh	—	—	6,500
2019-12-02	Acorda Therapeutics, Inc.S Sale	President, Intl and GC	SSale	−2,227 sh	$1.60	−$3,552.733	117,420
2019-11-07	Acorda Therapeutics, Inc.Employee Stock Option (right to buy)A Award	President, Intl and GC	AAward	+80K sh	—	—	80,000
2019-05-23	RIGLRIGEL PHARMACEUTICALS INC · Stock Option (Right to Buy)A Award	Director	AAward	+13.8K sh	—	—	13,750
2019-04-01	RIGLRIGEL PHARMACEUTICALS INC · Stock Option ( Right to Buy)A Award	Director	AAward	+80K sh	—	—	80,000
2019-03-14	SLSSELLAS Life Sciences Group, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+25K sh	—	—	25,000
2019-03-08	Acorda Therapeutics, Inc.A Award	President, Intl and GC	AAward	+12.8K sh	—	—	119,647
2019-03-08	Acorda Therapeutics, Inc.Employee Stock Option (right to buy)A Award	President, Intl and GC	AAward	+21.4K sh	—	—	21,355
2019-02-21	Acorda Therapeutics, Inc.F Tax Payment	President, Intl and GC	FTax Payment	−953 sh	$13.38	−$12.8K	106,834
2018-12-22	Acorda Therapeutics, Inc.A Award	President, Intl and GC	AAward	+2,500 sh	—	—	107,787
2018-12-03	Acorda Therapeutics, Inc.S Sale	President, Intl and GC	SSale	−3,067 sh	$20.52	−$62.9K	105,287
2018-11-05	Acorda Therapeutics, Inc.F Tax Payment	President, Intl and GC	FTax Payment	−955 sh	$20.28	−$19.4K	108,354
2018-09-10	Acorda Therapeutics, Inc.A Award	President, Intl and GC	AAward	+2,500 sh	—	—	109,309
2018-06-12	SLSSELLAS Life Sciences Group, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+5,500 sh	—	—	5,500
2018-03-13	SLSSELLAS Life Sciences Group, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+11K sh	—	—	11,000
2018-03-08	Acorda Therapeutics, Inc.F Tax Payment	President, Intl and GC	FTax Payment	−2,470 sh	$25.65	−$63.4K	106,809
2018-03-05	Acorda Therapeutics, Inc.M Exercise/Conversion	President, Intl and GC	MExercise/Conversion	+2,980 sh	$19.81	+$59K	111,553
2018-03-05	Acorda Therapeutics, Inc.F Tax Payment	President, Intl and GC	FTax Payment	−2,274 sh	$25.95	−$59K	109,279
2018-03-05	Acorda Therapeutics, Inc.Employee Stock Option (right to buy)M Exercise/Conversion	President, Intl and GC	MExercise/Conversion	−2,980 sh	—	—	0
2018-02-22	Acorda Therapeutics, Inc.A Award	President, Intl and GC	AAward	+6,463 sh	—	—	108,573
2018-01-19	Acorda Therapeutics, Inc.M Exercise/Conversion	President, Intl and GC	MExercise/Conversion	+34.5K sh	$19.81	+$684K	136,630
2018-01-19	Acorda Therapeutics, Inc.S Sale	President, Intl and GC	SSale	−34.2K sh	$27.58	−$942K	102,460

Recent filings

Accepted (ET)
May 194
Wasman Jane0000905148-26-002535
SEC(opens sec.gov)
Jan 94
Wasman Jane0001104659-26-002491
SEC(opens sec.gov)
Jun 24
Wasman Jane0001104659-25-055495
SEC(opens sec.gov)
May 284
Wasman Jane0000905148-25-001936
SEC(opens sec.gov)
Jan 144
Wasman Jane0001104659-25-003498
SEC(opens sec.gov)
May 294
Wasman Jane0000905148-24-001656
SEC(opens sec.gov)
Jan 254
Wasman Jane0001104659-24-006397
SEC(opens sec.gov)
Jul 124
Wasman Jane0001140361-23-034288
SEC(opens sec.gov)
Feb 34
Wasman Jane0001104659-23-010629
SEC(opens sec.gov)
Jan 114
Wasman Jane0001368148-23-000017
SEC(opens sec.gov)
Sep 204
Wasman Jane0001368148-22-000131
SEC(opens sec.gov)
May 234
Wasman Jane0001140361-22-020307
SEC(opens sec.gov)

Companies

Address

RIGEL PHARMACEUTICALS, INC. 611 GATEWAY BLVD, SUITE 900

SOUTH SAN FRANCISCO, CA, 94080